Clinical Trial Update: Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating sorafenib in combination with ifosfamide for soft tissue sarcoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)
• Nexavar (Sorafenib)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: UNKNOWN